Awakn Life Sciences (TSE:AWKN) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Awakn Life Sciences Corp. is collaborating with Eurofins Discovery and Graft Polymer to advance its pre-clinical program for developing new therapeutics aimed at treating mental health and addiction disorders, including Alcohol Use Disorder and PTSD. This partnership is a key move in Awakn’s strategy to bring innovative treatments to the market, potentially benefiting millions suffering from these conditions in North America and Europe.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.